Study details
Enrolling now
A Pilot Trial to Assess PYLARIFY PET-CT for Detecting Metastasis
M.D. Anderson Cancer Center
NCT IDNCT05394259ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
36
Study length
about 4.3 years
Ages
18+
Locations
1 site in TX
What this study is about
This trial is testing if PYLARIFY (piflufolastat F18) can be used in imaging scans for patients with breast cancer, liver cancer, or pancreatic cancer. The goal is to see how well PYLARIFY detects metastasis compared to the standard method of diagnosis.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Piflufolastat F18
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
Diagnostic Agent (Imaging Contrast Activity)
Body systems
Oncology